Salwan Al Mutar, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of it's Division of Hematology Oncology. A medical oncologist, he specializes in treating gastrointestinal cancers.
Dr. Al Mutar earned his medical degree at the Al-Mustansiriyah University College of Medicine in Iraq. Drawn by the rapidly growing science of oncology and the higher level of communication skill it takes to take care of cancer patients he developed an interest in Medical Oncology prior to residency, while working as a Research Assistant in Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center. He completed his residency in internal medicine at Wayne State University School of Medicine and then received advanced training through a fellowship in medical oncology at the University of Texas Medical Branch at Galveston and a clinical research fellowship in gastrointestinal cancer at The Ohio State University.
Board certified in both internal medicine and medical oncology, he joined the UT Southwestern faculty in 2020.
Dr. Al Mutar’s clinical and research interests include gastrointestinal cancers, geriatric oncology, and improving cancer care quality and delivery. Dr. Al Mutar obtained a master's degree in Translational Pharmacology and Clinical Trial Design Specialization from the Ohio State University in December 2021 to strengthen that commitment to improve access to high quality clinical trials.
He is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.
Dr. Al Mutar’s interests outside of medicine include soccer, water sports and travelling.
- Medical School
- University of Al-Mustansiririah College of Medicine, Iraq (2011)
- Wayne State University School of Medicine (2017), Internal Medicine
- University of Texas Medical Branch (2019), Medical Oncology
- Research Fellowship
- The Ohio State University Medical Center (2020), Gi Oncology
- Gastrointestinal Oncology
- Geriatric Oncology
- Quality of Care Improvement
- Oxaliplatin-induced Pulmonary Toxicity: A Rare but Serious Complication.
- Suthar KH, Al Mutar S, Venkatesan R, Cureus 2020 Mar 12 3 e7483
Honors & Awards
- Ohio State Honor Society
Ohio State University (2019)
- American Association of Cancer Research (2019)
- American Society of Clinical Oncology (2017)
- American Society of Hematology (2017)